Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease

Muscle and Nerve

Volumn 22, Issue 9, 1999, Pages 1228-1233

  Tarnopolsky, M A ^a   Parise, G ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Atrophy; Creatine; Creatine supplement; Muscle biopsy; Phosphocreatine

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOCHEMICAL MARKER; CREATINE PHOSPHATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSTROPHY; HIGH ENERGY PHOSPHATE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MUSCLE BIOPSY; MYOPATHY; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPECTROSCOPY;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; BIOPSY; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLES; NEUROMUSCULAR DISEASES; PHOSPHOCREATINE;

EID: 0032822221     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.0.CO;2-6     Document Type: Article

References (28)

1. Arnold DL, Taylor DJ, Radda GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
2. Benedict JD, Kalinsky HJ, Scarrone LA, Wertheim R, DeWitt S. The origin of urinary creatinine in progressive muscular dystrophy. J Clin Invest 1955;34:141-145.
3. Bogdanis GC, Nevill ME, Boobis LH, Lakomy HKA. Contribution of phosphocreatine and aerobic metabolism to energy supply during repeated spring exercise. J Appl Physiol 1996; 80:876-884.
4. Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, Bryan RN, Hurko O. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol 1990;27:626-630.
5. Forsberg AM, Nilsson E, Werneman J, Bergstrom J, Hultman E. Muscle composition in relation to age and sex. Clin Sci 1991;81:249-256.
6. Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf CJ, Nyquist O, Sylven C. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 1995;30:413-418.
7. Greenhaff PL, Bodin K, Soderlund K, Hultman E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994;266 (Endocrinol Metab 29):E725-E730.
8. +-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. J Biol Chem 1993;268:8418-8421.
9. Harris RC, Hultman E, Nordesjö L-O. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 1974; 33:109-120.
10. Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992;83:367-374.
11. Hemmer W, Wallimann T. Functional aspects of creatine kinase in brain. Dev Neurosci 1993;15:249-260.
12. Ingwall JS, Weiner CD, Morales MF, Davis E, Stockdale FE. Specificity of creatine in the control of muscle protein synthesis. J Cell Physiol 1974;63:145-151.
13. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and possible therapy with coenzyme Q10. Ann Neurol 1997;41:160-165.
14. Mainwood GW, De Zepetnek JT. Post-tetanic responses in creatine-depleted rat EDL muscle. Muscle Nerve 1985;8: 774-782.
15. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 1991;41:114-120.
16. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 1998;18:156-163.
17. Meyer RA, Brown TR, Krilowicz BL, Kushmerick MJ. Phosphagen and intracellular pH changes during contraction of creatine-depleted rat muscle. Am J Physiol 1986;250: C264-C274.
18. 13PNMR spcctroscopy to the study of striated muscle metabolism. Am J Physiol 1982;242 (Cell Physiol 11):C1-C11.
19. Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR, Olsen NJ. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arth Rheum 1994;37:736-746.
20. Sahlin K, Harris RC, Hultman E. Resynthesis of creatine phosphate in human muscle after exercise in relation to intramuscular pH and availability of oxygen. Scand J Clin Lab Invest 1979;39:551-558.
21. Soderlund K, Hultman E. Effects of delayed freezing on content of phospagens in human skeletal muscle biopsy samples. J Appl Physiol 1986;61:832-835.
22. + responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 1997;89: 93-103.
23. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997;20:1502-1509.
24. Vandenberghe K, Goris M, Van Hecke P, Leemputte MV, Vangerven L, Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 1997;83:2055-2063.
25. Vandenberghe K, Van Hecke P, Van Leemputte M, Vanstapel F, Hespel P. Phosphocreatine resynthesis is not affected by creatine loading. Med Sci Sports Exerc 1999;31:236-242.
26. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissue with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992;281:21-40.
27. Westerblad H, Lāanergren J. Reduced maximum shortening velocity in the absence of phosphocreatine observed in intact fibres of Xenopus skeletal muscle. J Physiol (Lond) 1995;482: 383-390.
28. Younkin DP, Berman P, Sladky J, Chee C., Bank W, Chance B. P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987;37:165-169.